Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.


OTCQX:RHHBY - Post by User

Roche Holdings ADR
Bullboard Posts
User Avatar Image
(0)
•••
Post by WesternInvestoron Jun 21, 2018 2:48pm
251 Views
Post# 28207690

Acquires Shares of Foundation Medicine for $2.4B (EN & CH)

Acquires Shares of Foundation Medicine for $2.4B (EN & CH)
Not for distribution in US:

Roche Acquires Remaining Shares of Foundation Medicine for $2.4 Billion

Three years after acquiring a majority stake in Cambridge, Mass.-based Foundation Medicine, Pharma giant Roche has agreed to buy up all outstanding shares for about $2.4 billion and bring the company’s sequencing diagnostics platform under the Roche umbrella....
https://nai500.com/blog/2018/06/roche-acquires-remaining-shares-of-foundation-medicine-for-2-4-billion/

Chinese version:
https://nai500.com/zh-hans/blog/2018/06/%E7%91%9E%E5%A3%AB%E7%BD%97%E6%B0%8F24%E4%BA%BF%E7%BE%8E%E5%85%83%E6%94%B6%E8%B4%AD%E7%BE%8E%E5%9B%BD%E5%9F%BA%E7%A1%80%E5%8C%BB%E5%AD%A6/
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities